참고문헌
- Airoldi I, Guglielmino R, Carra G, et al (2002). The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes. Haematologica, 87, 434-42.
- Boes M, Prodeus AP, Schmidt T, et al (1998). A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med, 188, 2381-6. https://doi.org/10.1084/jem.188.12.2381
- Clark IA (2007). How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev, 18, 335-43. https://doi.org/10.1016/j.cytogfr.2007.04.002
- Correa P (2013). Gastric cancer: overview. Gastroenterol Clin North Am, 42, 211-7. https://doi.org/10.1016/j.gtc.2013.01.002
- Fritzsche FR, Kristiansen G, Riener MO, et al (2010). GOLPH2 expression may serve as diagnostic marker in seminomas. BMC Urol, 10, 4. https://doi.org/10.1186/1471-2490-10-4
- Fritzsche FR, Riener MO, Dietel M, et al (2008). GOLPH2 expression in renal cell cancer. BMC Urol, 8, 15. https://doi.org/10.1186/1471-2490-8-15
- Gong Y, Long Q, Xie H, et al (2012). Cloning and characterization of human Golgi phosphoprotein 2 gene (GOLPH2/GP73/GOLM1) promoter. Biochem Biophys Res Commun, 421, 713-20. https://doi.org/10.1016/j.bbrc.2012.04.067
- Gray PW, Goeddel DV (1982). Structure of the human immune interferon gene. Nature, 298, 859-63. https://doi.org/10.1038/298859a0
- Hu L, Li L, Xie H, et al (2011).The Golgi localization of GOLPH2 (GP73/GOLM1) is determined by the transmembrane and cytoplamic sequences. PLoS One, 6, e28207. https://doi.org/10.1371/journal.pone.0028207
- Kim HJ, Lv D, Zhang Y, et al (2012). Golgi phosphoprotein 2 in physiology and in diseases. Cell Biosci, 2, 31. https://doi.org/10.1186/2045-3701-2-31
- Kim JJ (2013). Upper gastrointestinal cancer and reflux disease. J Gastric Cancer, 13, 79-85. https://doi.org/10.5230/jgc.2013.13.2.79
- Kristiansen G, Fritzsche FR, Wassermann K, et al (2008). GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer, 99, 939-48. https://doi.org/10.1038/sj.bjc.6604614
- Laxman B, Morris DS, Yu J, et al (2008). A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res, 68, 645-9. https://doi.org/10.1158/0008-5472.CAN-07-3224
- Old LJ (1985). Tumor necrosis factor (TNF). Science, 230, 630-2. https://doi.org/10.1126/science.2413547
- Peluso I, Pallone F, Monteleone G (2006). Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol, 12, 5606-10.
- Pietrantonio F, De Braud F, Da Prat V, et al (2013). A review on biomarkers for prediction of treatment outcome in gastric cancer. Anticancer Res, 33, 1257-66.
- Reid RR, Prodeus AP, Khan W, et al (1997). Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J Immunol, 159, 970-5.
- Riener MO, Stenner F, Liewen H, et al (2009). Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology, 49, 1602-9. https://doi.org/10.1002/hep.22843
-
Rival YA. Maschio D, Rabiet MJ, et al (1996). Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-
${\alpha}$ and IFN-${\gamma}$ . J Immunol, 157, 1233. -
Romer LH, McLean NV, Yan HC, et al (1995). IFN-
${\gamma}$ and TNF-${\alpha}induce$ redistribution of PECAM-1 (CD31) on human endothelial cells. J Immunol, 154, 6582. - Roobol MJ, Haese A, Bjartell A (2011).Tumour markers in prostate cancer III: biomarkers in urine. Acta Oncol, 50 (Suppl 1), 85-9. https://doi.org/10.3109/0284186X.2010.524935
- Said EA, Dupuy FP, Trautmann L, et al (2010). Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nature Med, 16, 452-9. https://doi.org/10.1038/nm.2106
- Schoenborn JR, Wilson CB (2007). Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol, 96, 41-101. https://doi.org/10.1016/S0065-2776(07)96002-2
- Schroder K, Hertzog PJ, Ravasi T, et al (2004). Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol, 75, 163-89.
- Sugano K (2013). Premalignant conditions of gastric cancer. J Gastroenterol Hepatol, 28, 906-11. https://doi.org/10.1111/jgh.12209
- Wajant H, Pfizenmaier K, Scheurich P (2003). Tumor necrosis factor signaling. Cell Death Differ, 10, 45-65. https://doi.org/10.1038/sj.cdd.4401189
-
Wang L, Zhao YH, Liu Y, et al (2013). IFN-
${\gamma}$ and TNF-${\alpha}$ synergistically induce mesenchymal stem cell impairment and tumorigenesis via$NF{\kappa}B$ signaling. Stem Cells, 31, 1383-95. https://doi.org/10.1002/stem.1388 - Wei S, Dunn TA, Isaacs WB, et al (2008). GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus. Prostate, 68, 1387-95. https://doi.org/10.1002/pros.20806
- Wolf SF, Temple PA, Kobayashi M, et al (1991). Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol, 146, 3074-81.
- Zhang F, Gu Y, Li X, et al (2010). Up-regulated Golgi phosphoprotein 2 (GOLPH2) expression in lung adenocarcinoma tissue. Clin Biochem, 43, 983-91. https://doi.org/10.1016/j.clinbiochem.2010.05.010
피인용 문헌
- Golgi-Related Proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in Cutaneous Melanoma: Patterns of Expression and Prognostic Significance vol.17, pp.10, 2016, https://doi.org/10.3390/ijms17101619